Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Éric Bellissant

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Therapie|January 12, 2020
Dominique Deplanque, Ségolène de Retz, Éric Bellissant, et al.
Therapie|January 15, 2020
How to attract doctors to careers in the fields of pharmaceutical medicine and medical devices?Dominique Deplanque, Ségolène de Retz, Éric Bellissant, et al.
Clinical Pharmacology and Therapeutics|March 13, 2019
Pharmacokinetic Parameters of Infliximab Influence the Rate of Relapse After De-Escalation in Adults With Inflammatory Bowel DiseasesAntoine Petitcollin, Charlène Brochard, Laurent Siproudhis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2019
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with <sup>188</sup>Re-SSS Lipiodol radioembolizationKostas Delaunay, Julien Edeline, Yan Rolland, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|June 20, 2022
Anthony Chapron, Marie-Astrid Metten, Arnaud Maury, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Therapie|January 12, 2020
Dominique Deplanque, Ségolène de Retz, Éric Bellissant, et al.
Therapie|January 15, 2020
How to attract doctors to careers in the fields of pharmaceutical medicine and medical devices?Dominique Deplanque, Ségolène de Retz, Éric Bellissant, et al.
Clinical Pharmacology and Therapeutics|March 13, 2019
Pharmacokinetic Parameters of Infliximab Influence the Rate of Relapse After De-Escalation in Adults With Inflammatory Bowel DiseasesAntoine Petitcollin, Charlène Brochard, Laurent Siproudhis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2019
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with <sup>188</sup>Re-SSS Lipiodol radioembolizationKostas Delaunay, Julien Edeline, Yan Rolland, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|June 20, 2022
Anthony Chapron, Marie-Astrid Metten, Arnaud Maury, et al.
Pageof 1